Trending Now
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) Fiscal Q4 2020 Financials Highlight Failure To...
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) released its financials for its fiscal quarter ended June 30, 2020, revealing that the three months did not yield in...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Could Carbon Markets be approaching a Trillion-Dollar Valuation?
One of the most highly sought-after investment themes since the tech boom in the late 90s might be a sector to which...
MAKE IT MODERN
LATEST REVIEWS
ImmunityBio’s (IBRX) Latest Financial Outlook and Medical Innovation Spotlight: A Glimpse...
In the dynamic world of biotech investments, ImmunityBio Inc. (NASDAQ: IBRX) showcases a steady financial outlook as projected by Wall Street analysts....
MAKE IT MODERN
PERFORMANCE TRAINING
Iterum Therapeutics plc (NASDAQ:ITRM) Reports A Loss Of $98.9 Million In Q1 2021: FDA...
Iterum Therapeutics plc (NASDAQ:ITRM) widened its loss to $98.91 Million in Q1 2021. It is mainly because of non-cash adjustments.
The company maintains short-term investments,...
Evogene Ltd’s (NASDAQ: EVGN) AgPlenus Ltd., Subsidy Has Announced That It Has Achieved Positive...
Evogene Ltd (NASDAQ: EVGN) subsidy, AgPlenus Ltd., recently announced positive results. The results were announced for a Proof of Concept (POC) testing of a...
Party City Holdco Inc (NYSE:PRTY) is surging and here’s why
Party City Holdco Inc (NYSE:PRTY) is surging and here are few reasons
1. The shares are oversold after a...
Crypto Stocks Enter a New Age (CAN, RIOT, ISWH, MARA)
The Cryptocurrency boom that got full-throated traction last fall has only accelerated, and the key point in play is legitimacy.
Aimmune Therapeutics Inc. (NASDAQ:AIMT) Announces Positive Results On PALFORZIA Study In Management Of Peanut...
Aimmune Therapeutics Inc. (NASDAQ:AIMT) has announced new data in its two-year study that shows the long-term efficacy of PALFORZIA daily treatment in peanut allergy...
MAKE IT MODERN
